Skip to main content

Update on GINA - It isn't too late to act!

Here's an update on the status of the Genetic Non-Discrimination Act. It actually didn't go for a vote this last week, so if you didn't get around to writing to your member of Congress, it isn't too late. Knock yourself out! Grin! I'm not including the list of supporting organizations. It's interesting, but very long. I can assure you, the Hermansky-Pudlak Syndrome Network's name is on it.

Thanks everyone!

Dear all,
Our colleagues on the Hill tell us that it appears all systems are go for GINA this week – last week, the transportation bill took longer than expected. It might be that the bill on the floor ahead of GINA on Monday will also take a while, but the hope is that GINA can fly once it does hit the floor (probably Tuesday or later, my personal guess – one cannot time the progression of bills accurately).Staffers tell us that your calls and faxes have made the difference – cosponsors are being added every few days (check to see if your senator is a cosponsor - http://thomas.loc.gov/cgi-bin/bdquery/z?d110:SN00358:@@@P), and all Senators are hearing that this issue is a major one for their constituents – we have to keep this level of interest up until passage – so please reach out even further to all of your networks.If your organization is not in the list below, please send your organization’s name to: policy@geneticalliance.org it is time we all stood together – this is a winning team. We welcome nonmedical, non-health organizations as well.Below the list of organizations, you will also find the instructions for taking action and getting your friends, relatives and colleagues to take action.This is extraordinary, my friends, after more than a decade of work, we are about to see the incredible dedication of thousands of people bear fruit. I am awed at your commitment, one and all!

Thanks so much!Sharon (for the steering committee of the Coalition for Genetic Fairness)

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria